Profile
| Metric | Value |
|---|---|
| Full Name | Dr. Reddy's Laboratories Limited |
| Ticker | NYSE: RDY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | India |
| IPO | |
| Indexes | Not included |
| Website | drreddys.com |
| Employees | 27,811 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $13.86 | |
| Price, 1D Change | +0.29% | |
| Market Cap | $12B | |
| TTM Dividend Yield | 0.67% | |
| PE Ratio | 16.97 | |
| Beta | 0.44 | |
| Revenue | $4B | |
| Revenue, 1Y Change | +14.19% | |
| EPS | $0.80 | |
| EPS, 1Y Change | -0.64% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.09 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 5:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.80 | |
| EPS Estimate | N/A | $61.53 |
| EPS Est. Change | N/A | +7,574.94% |
| Revenue | $3.85B | |
| Revenue Estimate | N/A | $341.93B |
| Revenue Est. Change | N/A | +8,780.59% |
| Current Price | $13.86 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.79 | $0.81 | -78.71% | |
| $70.93 | $0.80 | -98.87% | |
| $61.53 | N/A | +7,574.94% | |
| $56.62 | N/A | +6,962.49% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.31B | $3.37B | +1.85% | |
| $323.36B | $3.85B | -98.81% | |
| $341.93B | N/A | +8,780.59% | |
| $349.21B | N/A | +8,969.66% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -10.12% | |
| Price, 3Y | +31.50% | |
| Market Cap, 1Y | -10.18% | |
| Market Cap, 3Y | +31.82% | |
| Revenue, 1Y | +14.19% | |
| Revenue, 3Y | +33.82% | |
| EPS, 1Y | -0.64% | |
| EPS, 3Y | +110.81% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $13.86 | |
| SMA 200 | $14.20 | |
| SMA 200 vs Price | +2.43% | |
| SMA 50 | $13.92 | |
| SMA 50 vs Price | +0.45% | |
| Beta | 0.44 | |
| ATR | $0.19 | |
| 14-Day RSI | 43.74 | |
| 10-Day Volatility | 9.48% | |
| 1-Year Volatility | 24.27% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.09 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 0.69% | |
| Total Dividend | $0.10 | |
| Dividends Paid | $78.80M | |
| Payout Ratio | 11.64% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $3.85B | |
| EPS | $0.80 | |
| Gross Profit | $2.13B | |
| Gross Margin | 55.44% | |
| Operating Profit | $822.04M | |
| Operating Margin | 21.35% | |
| Net Income | $677.08M | |
| Net Margin | 17.58% | |
| EBITDA | $1.02B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.14 | |
| Current Ratio | 1.92 | |
| Quick Ratio | 1.37 | |
| - | ||
| F-Score | 4 | |
| Altman Z-Score | 6.12 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 16.97 | |
| PS Ratio | 2.90 | |
| PB Ratio | 2.86 | |
| EV/EBITDA | 15.73 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $3.90B | |
| Cash & Equivalents | $677.50M | |
| Total Assets | $5.77B | |
| Current Assets | $2.93B | |
| Total Liabilities | $1.82B | |
| Current Liabilities | $1.53B | |
| Total Debt | $547.15M | |
| Short Term Debt | $455.14M | |
| Accounts Payable | $234.61M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $3.18B | |
| Operating Expenses | $1.31B | |
| Cost Of Goods Sold | $1.72B | |
| SG&A | $1.11B | |
| D&A | $201.76M | |
| Interest Expense | $0.00 | |
| Income Tax | $231.10M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $547.83M | |
| CFI | -$726.81M | |
| CFF | $264.87M | |
| Capex | $406.85M | |
| Free Cash Flow | $140.98M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HSBC | → | |
| Barclays | → | |
| Barclays | → | |
| Barclays | → | |
| Barclays | → | |
| Barclays | → | |
| Barclays | ||
| Barclays | ||
| Barclays | ||
| Barclays |
Analyst sentiment
Institutional ownership
Screeners with RDY
Data Sources & References
- RDY Official Website www.drreddys.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1135951/000157587225000633/0001575872-25-000633-index.html
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1135951/000157587225000393/0001575872-25-000393-index.htm
- RDY Profile on Yahoo Finance finance.yahoo.com/quote/RDY
- RDY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rdy
FAQ
What is the ticker symbol for Dr. Reddy's Laboratories Limited?
The ticker symbol for Dr. Reddy's Laboratories Limited is NYSE:RDY
Does Dr. Reddy's Laboratories Limited pay dividends?
Yes, Dr. Reddy's Laboratories Limited pays dividends. The last payment was $0.09, with an ex-dividend date on July 25, 2025
What sector is Dr. Reddy's Laboratories Limited in?
Dr. Reddy's Laboratories Limited is in the Healthcare sector
What industry is Dr. Reddy's Laboratories Limited in?
Dr. Reddy's Laboratories Limited is in the Specialty & Generic Drug Manufacturers industry
What country is Dr. Reddy's Laboratories Limited based in?
Dr. Reddy's Laboratories Limited is headquartered in India
When did Dr. Reddy's Laboratories Limited go public?
Dr. Reddy's Laboratories Limited initial public offering (IPO) was on April 11, 2001
Is Dr. Reddy's Laboratories Limited in the S&P 500?
No, Dr. Reddy's Laboratories Limited is not included in the S&P 500 index
Is Dr. Reddy's Laboratories Limited in the NASDAQ 100?
No, Dr. Reddy's Laboratories Limited is not included in the NASDAQ 100 index
Is Dr. Reddy's Laboratories Limited in the Dow Jones?
No, Dr. Reddy's Laboratories Limited is not included in the Dow Jones index
When was Dr. Reddy's Laboratories Limited last earnings report?
Dr. Reddy's Laboratories Limited's most recent earnings report was on October 24, 2025
When does Dr. Reddy's Laboratories Limited report earnings?
The next expected earnings date for Dr. Reddy's Laboratories Limited is January 21, 2026
